Dr. Michael L Gross's research group at Washington University focuses on understanding the aggregation of amyloid proteins, particularly in relation to Alzheimer's disease. By utilizing advanced techniques like mass spectrometry and protein footprinting, the lab investigates how these proteins misfold and interact with each other and lipids, honing in on potential therapeutic targets. This innovative approach aims to uncover the complexities of protein behavior in neurodegenerative conditions, contributing valuable insights to the field of neurological research.

At the Washington University Omics Production Center, we focus on understanding human health and disease across diverse populations through advanced data collection and integration of multiple types of biological information. By using cutting-edge techniques, we analyze genes, proteins, and metabolites to find innovative solutions for early disease detection and prevention. Our work lays the groundwork for improved public health strategies and a deeper understanding of disease mechanisms.